Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Combination of Midostaurin and Gemtuzumab Ozogamicin in First-line Standard Therapy for Acute Myeloid Leukemia (MOSAIC)	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 1 / Phase 2	2025-09-08		NCT04385290

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Novartis Pharmaceuticals	432
Pfizer	431
Technische Universität Dresden	62

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Gemeinschaftsklinikum Mittelrhein gGmbH	Koblenz	Germany	1
Johann Wolfgang Goethe-Universität	Frankfurt am Main	Germany	2
Klinikum Chemnitz gGmbH	Chemnitz	Germany	32
Klinikum Mannheim gGmbH	Mannheim	Germany	2
Klinikum Nürnberg-Nord	Nuremberg	Germany	2
Krankenhaus Barmherzige Brüder	Regensburg	Germany	5
LMU Klinikum, Campus Großhadern	München	Germany	1
Philipps-Universität Marburg Fachbereich Medizin	Marburg	Germany	2
Rems-Murr-Klinikum Winnenden	Winnenden	Germany	2
Robert-Bosch-Krankenhaus	Stuttgart	Germany	11
Rotkreuzklinikum München gGmbH	München	Germany	1
Universitätsklinikum Aachen	Aachen	Germany	18
Universitätsklinikum Augsburg	Augsburg	Germany	18
Universitätsklinikum Dresden	Dresden	Germany	8
Universitätsklinikum Essen	Essen	Germany	16
Universitätsklinikum Halle	Halle	Germany	7
Universitätsklinikum Heidelberg	Heidelberg	Germany	47
Universitätsklinikum Jena	Jena	Germany	1
Universitätsklinikum Leipzig	Leipzig	Germany	41
Universitätsklinikum Münster	Münster	Germany	35
Universitätsklinikum Schleswig-Holstein	Kiel	Germany	13

Clinical trials